Adenomas of the colon: Overexpression of p53 protein and risk factors

Endoscopy

Volumn 30, Issue 7, 1998, Pages 623-626

  Speroni, A H ^a   Vanzulli, S I ^a   Meiss, R P ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER RISK; CARCINOGENESIS; COLON ADENOMA; DYSPLASIA; ENDOSCOPIC SURGERY; FOLLOW UP; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE;

EID: 0031782960     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1001368     Document Type: Article

References (22)

1. Baker SJ, Preisinger AC, Millburn Jesupp J, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Research 1990; 50: 7717-22.
2. Purdie CA, O'Grady J, Piris J, et al. p53 Expression in colorectal tumors. Am J Pathol 1991; 138: 807-13.
3. Milsom JW. Pathogenesis of colorectal cancer. Surg Clin North Am 1993; 73: 1-11.
4. Zarbo RJ, Nakhleh RE, Brown RD, et al. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997; 79: 2073-86.
5. Muto T, Bussey H, Morson B. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
6. O'Brien MJ, Winaver SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-9.
7. Morson BC, Sobin LH. Histologic typing of intestinal tumours. International histological classification of tumours. 15, Geneva: World Health Organization, 1976.
8. Dix B, Robbins P, Carrello S, et al. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994; 70: 585-90.
9. Kaklamanis L, Gatter KC; Mortensen N, et al. p53 Expression in colorectal adenomas. Am J Pathol 1993; 142: 87-93.
10. Van den Berg FM, Baas IO, Polak MM, Oferhaus GJA. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 1993; 142: 381-5.
11. Pignatelli M, Stamp GWH, Kafiri G, et al. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992; 50: 683-8.
12. Sinicrope FA, Ruan SB, Cleary KR, et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-41.
13. Lim BHG, Song R, Grieu F, et al. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int J Cancer 1996; 69: 200-4.
14. Dix BR, Robbins P, Soong R, et al. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 1994; 59: 747-51.
15. Darmon E, Cleary KR, Wagovich MJ. Immunohistochemical analysis of p53 overexpression in human colonic tumors. Cancer Detect Prev 1994; 18: 187-95.
16. Negut AI, Jacobson JS, Ahsan H, et al. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 1995; 108: 402-8.
17. Speroni AH, Meiss RP, Calzona C, et al. Early colorectal cancer, follow-up after endoscopic polypectomy. Endoscopy 1988; 20: 18-20.
18. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with non familial colorectal polyps. Ann Intern Med 1993; 119: 836-43.
19. Winaver SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901-6.
20. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocystochemistry? J Pathol 1992; 162: 329-30.
21. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997; 150: 1547-52.
22. Finkelstein SD, Przygodzki R, Pricolo VE, et al. Prediction of biologic aggressiveness in colorectal cancer by p53/K-ras topographic genotyping. Mol Diagn 1996; 1: 5-27.